MAPT and Alzheimer disease: For example, amyloid-beta (Aβ) 42/Aβ40 ratio and phosphorylated tau derived from cerebrospinal fluid provide reliable indicators of Alzheimer’s disease, while emerging biomarkers like microtubule binding region (MTBR)-tau243 offer insights into disease progression.